Abstract
Early use of Botulinum toxin can be credited to ophthalmologist Dr. Allen Scott who communicated to the senior author and other in the late 1980s and early 1990s his observations of wrinkle effacement when treating blepharospasm. These observations led to early reports of Botulinum toxins employed to target specifically hyperfunctional frown lines. The great success of this molecule in aesthetic applications can thus be credited to the innovative thinking and initiative of clinicians with interest in advancing clinical care in contrast to the more common pharmaceutical-based, profit-motivated development of drugs and devices.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981; 79:734–70.
Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-a exotoxin. J Dermatol Surg Oncol. 1992;18(1):17–21.
Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev. 1992;56(1):80–99.
Mosby’s Medical Dictionary (8th ed. Elsevier; 2009).
Kim EJ, Ramirez AL, Reeck JB, Maas CS. Plast Reconstr Surg. 2003;112(5 Suppl):88S–93; discussion 94S–97.
Ramirez AL, Reeck J, Maas CS. Otolaryngol Head Neck Surg. 2002;126(5):459–67.
Dayan SH, Maas CS. Botulinum toxins for facial wrinkles: beyond glabellar lines. Facial Plast Surg Clin North Am. 2007;15(1):41–9.
Maas C, Kane MA, Bucay VW, Allen S, Applebaum DJ, Baumann L, Cox SE, Few JW, Joseph JH, Lorenc ZP, Moradi A, Nestor MS, Schlessinger J, Wortzman M, Lawrence I, Lin X, Nelson D. Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review. Aesthet Surg J. 2012;32(1 Suppl):8S–29.
Nettar KD, Yu KC, Bapna S, Boscardin J, Maas CS. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA. Arch Facial Plast Surg. 2011;13(6): 380–6.
Loos BM, Maas CS. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin North Am. 2003;11(4):439–43.
Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg. 2000;105(3):1129–35.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
(M4V 4913 kb)
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maas, C.S. (2014). Neuromodulators: Contemporary Indications and Techniques in the Upper and Midface. In: Myint, S. (eds) Nonsurgical Peri-orbital Rejuvenation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8388-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8388-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-8387-8
Online ISBN: 978-1-4614-8388-5
eBook Packages: MedicineMedicine (R0)